Bayesian Capital Management’s RXO RXO Stock Holding History

Bayesian Capital Management’s Portfolio RXO Stock Details RXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-16,814	Closed	-$391K	–	1074
2023 Q4	$391K	Buy	+16,814	New	+$338K	0.04%	437

Other funds holding RXO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Bayesian Capital Management's RXO Position: Q1 2024 in Review

Bayesian Capital Management sold out of RXO (RXO) in Q1 2024, closing a stake of 16,814 shares — an estimated $391K sold.

Bayesian Capital Management first reported a position in RXO in Q4 2023 and held it in 1 quarter. The position peaked at $391K in Q4 2023. 241 funds tracked by Wall St. Rank hold RXO as of Q1 2024.

Bayesian Capital Management reported no remaining RXO position as of Q1 2024 after selling out during the quarter.
Bayesian Capital Management sold 16,814 RXO shares in Q1 2024, an estimated $391K.
Bayesian Capital Management first reported a position in RXO in Q4 2023 and held it in 1 quarter.
Bayesian Capital Management's RXO position peaked at $391K in Q4 2023.
241 funds tracked by Wall St. Rank held RXO as of Q1 2024.

Based on Bayesian Capital Management's 13F filing for Q1 2024, filed 15 May 2024.